Gallatin, Michael,Ulrich, Roger G.,Giese, Neill A.,Lannutti, Brian,Yu, Albert,Miller, Langdon,Jahn, Thomas M.
申请号：
AU2016228272
公开号：
AU2016228272A1
申请日:
2016.09.16
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2016228272A120161006.pdf#####ABSTRACT The invention provides methods that relate to a novel therapeutic strategy for the treatment of hematological malignancies and inflammatory diseases. In particular, the method comprises administration of a compound of formula A, wherein R is H, halo, or C1-C6 alkyl； R' is C1-C6 alkyl； or a pharmaceutically acceptable salt thereof； and optionally a pharmaceutically acceptable excipient； and one or more additional therapeutic agents optionally selected from the group consisting of bendamustine, rituximab, and ofatumumab.
